Authors: ZAHEDI R WISNIESKI J DAVIS AE

Citation: R. Zahedi et al., C1 INHIBITOR - THE ROLE OF P2 IN DETERMINATION OF TARGET PROTEASE SPECIFICITY, Molecular immunology, 35(6-7), 1998, pp. 109-109

Authors: SINGER NG HONG L VOGT BA WISNIESKI J MARKS R

Citation: Ng. Singer et al., AUTOANTIBODY-MEDIATED C1 INHIBITOR (C1 INH) DEFICIENCY IN A TEENAGER WITH SLE PRESENTING AS INTESTINAL ANGIOEDEMA, Arthritis and rheumatism, 41(9), 1998, pp. 1383-1383

Authors: ZAHEDI R WISNIESKI J DAVIS AE

Citation: R. Zahedi et al., ROLE OF THE P2-RESIDUE OF COMPLEMENT-1 INHIBITOR (ALA(443)) IN DETERMINATION OF TARGET PROTEASE SPECIFICITY - INHIBITION OF COMPLEMENT AND CONTACT SYSTEM PROTEASES, The Journal of immunology, 159(2), 1997, pp. 983-988

Authors: SUWAIRI W BAHABRI S BEVING D WISNIESKI J WARMAN M

Citation: W. Suwairi et al., DYSFUNCTIONAL AND ANTIGENICALLY ABNORMAL C1Q RESULTING FROM A POINT MUTATION IN CODON-6 OF THE C-CHAIN, Arthritis and rheumatism, 40(9), 1997, pp. 1662-1662

Authors: DOWLING MJ ROERING WD CARLIN BA WISNIESKI J

Citation: Mj. Dowling et al., MULTIFACETED RELATIONSHIPS UNDER COOPETITION - DESCRIPTION AND THEORY, Journal of management inquiry, 5(2), 1996, pp. 155-167

Authors: DAVIS AE WISNIESKI J ZAHEDI R

Citation: Ae. Davis et al., REPLACEMENT OF ALA-443 WITH VAL IN C1 INHIBITOR ALTERS TARGET PROTEASE INHIBITORY SPECIFICITY, The FASEB journal, 9(4), 1995, pp. 1049-1049